Pharma Reviews: USFDA's off-patent drugs list may not offer much to Indian firms

Industry lobby group Indian Pharmaceutical Alliance (IPA) has been asking the USFDA to expedite the review of limited competition products for the ...
Read more: USFDA's off-patent drugs list may not offer much to Indian firms